{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:27:05Z","timestamp":1761568025848,"version":"build-2065373602"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,27]]},"abstract":"<jats:p>We report on the predictive value of multiple clinical and social factors for the development of new-onset psoriasis within a 6-month window following tumour necrosis factor inhibitor (TNFi) use. Results on multivariable analysis indicated that simultaneous methotrexate use and male sex were associated with 9.5-fold [95% confidence interval (CI) 5.27\u201316.92, P &amp;lt; 0.001] and 2.4-fold (95% CI 1.31\u20134.27, P = 0.004) increased odds of developing psoriasis after first TNFi use, respectively.<\/jats:p>","DOI":"10.1093\/ced\/llaf223","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T08:07:41Z","timestamp":1747296461000},"page":"2268-2270","source":"Crossref","is-referenced-by-count":0,"title":["Predictors for tumour necrosis factor inhibitor-induced paradoxical psoriasis in rheumatoid arthritis: an exploratory analysis informed by cross-validated random forest"],"prefix":"10.1093","volume":"50","author":[{"given":"Michael J","family":"Diaz","sequence":"first","affiliation":[{"name":"College of Medicine, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine T","family":"Tran","sequence":"additional","affiliation":[{"name":"School of Medicine, Indiana University , Indianapolis, IN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run Q","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"5 S1","key":"2025102707122443800_llaf223-B1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/abd1806-4841.20164456","article-title":"Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis","volume":"91","author":"de Vasconcellos","year":"2016","journal-title":"An Bras Dermatol"},{"key":"2025102707122443800_llaf223-B2","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.3390\/ijms25137018","article-title":"Paradoxical psoriasis in patients receiving therapy with tumor necrosis factor inhibitors: potential pathogenic mechanisms and the role of genetic factors","volume":"25","author":"Costin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2025102707122443800_llaf223-B3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jamadermatol.2022.2360","article-title":"Absolute and relative risk of new-onset psoriasis associated with tumor necrosis factor-\u03b1 inhibitor treatment in patients with immune-mediated inflammatory diseases: a Danish nationwide cohort study","volume":"158","author":"Thein","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2025102707122443800_llaf223-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the Boruta package","volume":"36","author":"Kursa","year":"2010","journal-title":"J Stat Software"},{"key":"2025102707122443800_llaf223-B5","first-page":"e42791","article-title":"Paradoxical tumor necrosis factor-alpha (TNF-\u03b1) inhibitor-induced psoriasis: a systematic review of pathogenesis, clinical presentation, and treatment","volume":"15","author":"Chokshi","year":"2023","journal-title":"Cureus"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf223\/63203603\/llaf223.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/11\/2268\/63203603\/llaf223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/11\/2268\/63203603\/llaf223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:12:31Z","timestamp":1761563551000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/11\/2268\/8133553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":5,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,5,16]]},"published-print":{"date-parts":[[2025,10,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf223","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,5,16]]}}}